These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI. Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737 [TBL] [Abstract][Full Text] [Related]
5. Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon. Richter S; Wuest M; Bergman CN; Krieger S; Rogers BE; Wuest F Mol Pharm; 2016 Apr; 13(4):1347-57. PubMed ID: 26973098 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of Körhegyi Z; Rózsa D; Hajdu I; Bodnár M; Kertész I; Kerekes K; Kun S; Kollár J; Varga J; Garai I; Trencsényi G; Borbély J Anticancer Res; 2019 May; 39(5):2415-2427. PubMed ID: 31092434 [TBL] [Abstract][Full Text] [Related]
7. The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study. Khalkhali M; Rostamizadeh K; Sadighian S; Khoeini F; Naghibi M; Hamidi M Daru; 2015 Sep; 23(1):45. PubMed ID: 26381740 [TBL] [Abstract][Full Text] [Related]
8. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system. Barahuie F; Dorniani D; Saifullah B; Gothai S; Hussein MZ; Pandurangan AK; Arulselvan P; Norhaizan ME Int J Nanomedicine; 2017; 12():2361-2372. PubMed ID: 28392693 [TBL] [Abstract][Full Text] [Related]
9. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI). Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135 [TBL] [Abstract][Full Text] [Related]
10. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26. Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications. Mahdavi M; Ahmad MB; Haron MJ; Namvar F; Nadi B; Rahman MZ; Amin J Molecules; 2013 Jun; 18(7):7533-48. PubMed ID: 23807578 [TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of surface modified Fe Sun JZ; Sun YC; Sun L J Photochem Photobiol B; 2019 Aug; 197():111547. PubMed ID: 31325773 [TBL] [Abstract][Full Text] [Related]
14. Bombesin-functionalized superparamagnetic iron oxide nanoparticles for dual-modality MR/NIRFI in mouse models of breast cancer. Li L; Wu C; Pan L; Li X; Kuang A; Cai H; Tian R Int J Nanomedicine; 2019; 14():6721-6732. PubMed ID: 31686805 [TBL] [Abstract][Full Text] [Related]
15. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation. Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085 [TBL] [Abstract][Full Text] [Related]
17. 44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET? Koumarianou E; Loktionova NS; Fellner M; Roesch F; Thews O; Pawlak D; Archimandritis SC; Mikolajczak R Appl Radiat Isot; 2012 Dec; 70(12):2669-76. PubMed ID: 23037921 [TBL] [Abstract][Full Text] [Related]
18. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties. Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571 [TBL] [Abstract][Full Text] [Related]
19. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of magnetofection efficiency using chitosan coated superparamagnetic iron oxide nanoparticles and calf thymus DNA. Sohrabijam Z; Saeidifar M; Zamanian A Colloids Surf B Biointerfaces; 2017 Apr; 152():169-175. PubMed ID: 28110038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]